JIPOAd
PARP
ESID
  • Users Online: 327
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
   Table of Contents
Coverpage
January-March 2019
Volume 2 | Issue 1
Page Nos. 1-18

Online since Thursday, January 24, 2019

Accessed 7,308 times.

PDF access policy
Journal allows immediate open access to content in HTML + PDF
View as eBookView issue as eBook
CitationsIssue citations
Access StatisticsIssue statistics
RSS FeedRSS
Show all abstracts  Show selected abstracts  Export selected to  Add to my list
EDITORIAL  

Optimizing Precision Oncology and Immunotherapy Strategies: Moving into the Next Stage of Cancer Medicine p. 1
Phoebe Lewis, Timothy A Yap
DOI:10.4103/JIPO.JIPO_26_18  
[HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta
ORIGINAL ARTICLE Top

The Study of Druggable Targets in Nonsquamous Non-Small-Cell Lung Cancer in the Middle East and North Africa p. 4
Abdul Rahman Jazieh, Adda Bounedjar, Fouad Al Dayel, Shamayel Fahem, Arafat Tfayli, Kakil Rasul, Hassan Jaafar, Mohammad Jaloudi, Turki Al Fayea, Hatim Q Al Maghrabi, Hanaa Bamefleh, Khaled Al Kattan, Blaha Larbaoui, Taha Filali, Hamed Al Husaini, Yosra Ali, in collaboration with the Arab Collaborative Hematology Oncology Group (ACHOG)
DOI:10.4103/JIPO.JIPO_22_18  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Citations (2) ]  [Sword Plugin for Repository]Beta
COMMENTARY Top

Opening new boundaries in biomarker detection: Awakening of middle east and North Africa Region p. 8
Christian Rolfo, Umberto Malapelle
DOI:10.4103/JIPO.JIPO_27_18  
[HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta
REVIEW ARTICLE Top

Extracellular signal-regulated kinase (ERK) inhibitors in oncology clinical trials p. 10
Haelee M Chin, David K Lai, Gerald S Falchook
DOI:10.4103/JIPO.JIPO_17_18  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Citations (2) ]  [Sword Plugin for Repository]Beta
SPECIAL ARTICLE Top

5th Annual immuno-oncology 360° conference: What to expect p. 17
Kate Woda
DOI:10.4103/2590-017X.249502  
[HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta
  Next Issue
  Previous Issue

CALL FOR PAPERS
Special issue 2019